Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.32, sa.8, ss.661-666, 2021 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 32 Sayı: 8
- Basım Tarihi: 2021
- Doi Numarası: 10.5152/tjg.2021.20512
- Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.661-666
- Anahtar Kelimeler: Fibrosis, metabolic syndrome, metabolic dysfunction-associated fatty liver disease, SEVERITY, STEATOHEPATITIS, PROGRESSION, OUTCOMES, NAFLD
- Recep Tayyip Erdoğan Üniversitesi Adresli: Hayır
Özet
Background: Metabolic syndrome (MS) is a condition that consists of several disorders, and the individual impact of these disorders on metabolic dysfunction-associated fatty liver disease (MAFLD) is still not clear in a combined diagnosis of MS. In this study, we aimed to investigate the effect of MS on advanced fibrosis in patients with MAFLD.